Does ASPIRIN Cause Malignant neoplasm progression? 85 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Malignant neoplasm progression have been filed in association with ASPIRIN (Aspirin). This represents 0.1% of all adverse event reports for ASPIRIN.
85
Reports of Malignant neoplasm progression with ASPIRIN
0.1%
of all ASPIRIN reports
36
Deaths
49
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ASPIRIN?
Of the 85 reports, 36 (42.4%) resulted in death, 49 (57.6%) required hospitalization, and 14 (16.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does ASPIRIN Cause?
Gastrointestinal haemorrhage (13,172)
Anaemia (4,568)
Off label use (4,283)
Dyspnoea (4,280)
Drug hypersensitivity (4,072)
Drug ineffective (4,061)
Upper gastrointestinal haemorrhage (3,411)
Epistaxis (3,214)
Rectal haemorrhage (3,057)
Acute kidney injury (2,976)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ASPIRIN Alternatives Have Lower Malignant neoplasm progression Risk?
ASPIRIN vs ASPIRIN DL-LYSINE
ASPIRIN vs ASPIRIN LYSINE
ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE
ASPIRIN vs ASPIRIN\CAFFEINE
ASPIRIN vs ASPIRIN\CARISOPRODOL